AZD6765 Severe Major Depressive Disorder (MDD) IV

NCT00781742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: AZD6765
DRUG: Placebo

Sponsor

AstraZeneca